Technivie

ombitasvir / paritaprevir / ritonavir

Used for Hepatitis C

Technivie is a once daily antiviral combination medication once used with ribavirin for the treatment of type 4 hepatitis C. It is no longer available and has been replaced by newer antiviral combination medications.

Reviewed by:

Hope Chang, PharmD, AAHIVP

Michelle Nguyen, PharmD

Last reviewed on May 31, 2021

Basics FAQs Dosage Prices Medicare

What is Technivie?

Drug facts

Common BrandsTechnivie(brand no longer available)

Drug ClassAntiviral Combo

Controlled Substance ClassificationNot a controlled medication

Generic StatusNo lower-cost generic available

AvailabilityDiscontinued

Common questions about Technivie

Technivie, a combination of two antiviral medications (ombitasvir, paritaprevir) and a booster medication (ritonavir), was used to treat hepatitis C type 4. The typical regimen was two tablets in the morning with a meal, in combination with another antiviral medication, ribavirin, for 12 weeks.

No, there are no brand or generic versions available in the U.S.

Providers didn't prescribe Technivie as often after new and improved oral medications became available. The newer agents don't need to be taken with ribavirin. As a result, the manufacturer stopped making the medication due to a lack of demand.